DRKS00010174
Recruiting
未知
Prospective, randomized, controlled, multicenter, operative study to evaluate the role of intraoperative sonography compared to the preoperative wire localization in the treatment of non-palpable breast cancer - US-WIRE-Trial
niversitätsfrauenklinik0 sites230 target enrollmentMarch 11, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- C50
- Sponsor
- niversitätsfrauenklinik
- Enrollment
- 230
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •written consent after verbal clarification by an
- •Study physician for this study is available
- •\- Histologically proven invasive breast cancer
- •\- Non\-palpable tumor
- •\- Indication for BEI
- •\- CT1b\-cT2
- •\- Female patient\> 18 years
- •\- Sonographically detectable tumor in two levels
- •\- Karnofsky Performance Status \- Index \=70% or ECOG \<2
Exclusion Criteria
- •\- Multifocal tumor
- •\- Recurrence of breast cancer
- •\- Tumor \<5mm
- •\- Inability to understand the meaning and purpose of the clinical trial or the comply with conditions for studying
- •OP capability not available
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective, multicenter, randomized, controlled, single-blind other clinical trial. What is the efficacy of pelvic floor biofeedback training with ACTICORE1® for stress incontinence?N39.3Stress incontinenceDRKS00027319ACTICORE GmbH124
Not yet recruiting
Not Applicable
Prospective, multicenter, randomized, controlled, single-blind other clinical trial. What is the efficacy of app-based biofeedback training with ACTICORE1® for female stress incontinence?N39.3Stress incontinenceDRKS00033971ACTICORE GmbH262
Active, not recruiting
Not Applicable
Prospektive, randomized, controlled, multicentre, partly double blind study to compare Disci/Rhus toxicodendron comp., placebo and waiting list in patients with chronic low back pain.chronic low back pain (chronic local or pseudoradiculaere low back pain due to e.g. degenerative basic illness).EUCTR2006-006390-24-DEWALA Heilmittel GmbH
Active, not recruiting
Phase 1
Multi-center, prospective, controlled, randomized, single-blinded study to evaluate the efficacy of vibrotactile neuro-feedback additionally to intake of Ginkgo biloba special extract EGb 761® for the treament of presby vertigo.Presby VertigoMedDRA version: 20.0 Level: PT Classification code 10047340 Term: Vertigo System Organ Class: 10013993 - Ear and labyrinth disordersTherapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]EUCTR2014-000303-28-DEDr. Willmar Schwabe GmbH & Co. KG120
Withdrawn
Phase 4
Prospective, Randomized, Controlled, Multicentre, Open Study Releas of Paclitaxel during PTA versus PTA alone for the treatment of de-novo occluded, stenotic or reoccluded, restenotic superficial femoral (SFA) or popliteal arteries.narrowing of the bloodvesselstenosis10003216NL-OMON35958Eurocor GmbH15